Durable complete response of classic Kaposi's sarcoma of the supraglottis with pegylated liposomal doxorubicin

Abstract

recurrence appeared. The patient was diagnosed with primary classic Kaposi’s Sarcoma (Type I) limited to the supraglottis. Conclusion Classic-type Kaposi’s sarcoma is usually slow growing and does not impair quality of life and survival in the short term, but aggressive forms may be life threatening and should be treated urgently. Systemic chemotherapy with pegylated liposomal doxorubicin is an affective and well-tolerated strategy also for limited-stage disease with rapid progression, however.